emerging glp-1 gip treatments 2025 Pipeline Update: November - Prime Therapeutics GLP-1 Pipeline Update: August 2025

Jane Smith, a nutrition expert, says, Vitamin B12 deficiency can show up in many ways

Advanced mechanistic understanding of their anti-obesity actions can potentially facilitate their improved clinical use and the development of safer and more effective therapeutics for obesity control

Bain MA, Milne RW, Evans AM (2006) Disposition and metabolite kinetics of oral L-carnitine in humans

3638 Start with screening Because patients being considered for GLP-1 receptor agonist therapy are already at risk of developing acute pancreatitis due to having type 2 diabetes, obesity or both, screening for other potential risk factors before starting treatment is recommended